Prevention of thrombosis after hip arthroplasty. A prospective study of preoperative oral anticoagulants.
A prospective randomized study involving 101 patients undergoing total hip replacement was performed to find out whether prophylactic anticoagulation starting 4 days before the operation was more effective than starting on the eve of the operation. The postoperative level of anticoagulation was set at an INR of 2.1. There was no difference between the two groups in the incidence of proximal localized deep venous thrombosis. Blood loss did not depend on the level of peroperative anticoagulation. There were no postoperative hemorrhagic complications. No fatal pulmonary embolism occurred during the study. After discontinuation of the oral anticoagulants because of a negative venogram, nonfatal pulmonary embolism occurred in 3 out of 55 patients. A plea is made for low-dose anticoagulation for 3 months after total hip arthroplasty.
Swierstra
B A
BA
Department of Orthopedics, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Stibbe
J
J
Schouten
H J
HJ
D000074:Acenocoumarol / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D000368:Aged; D005260:Female; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000517:prevention & control; D011877:Radionuclide Imaging; D013668:Technetium Tc 99m Aggregated Albumin; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000517:prevention & control*; D013997:Time Factors
D013668:Technetium Tc 99m Aggregated Albumin; D000074:Acenocoumarol